Physician profile
Conor Blanco
NPI 1770978025
$2,659.86
in general payments reported to CMS, 2019-2025
8 companies · $994 in 2025
The $994 reported for 2025 was more than what 85% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $280 · 2023: $853 · 2024: $416 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,766.86 | 2022-2025 | |
| Optinose US, INC. | $364.48 | 2023-2025 | |
| Cochlear Americas | $228.45 | 2021-2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $124.09 | 2025 | Nucala |
| Advanced Bionics, LLC | $66.18 | 2022 | |
| Integra Lifesciences Corporation | $66.06 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic, INC. | $25.72 | 2025 | Propel |
| Greer Laboratories, INC. | $18.02 | 2025 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conor Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.